Drug Formulation Global Market Report 2025

Description

Drug formulation refers to the process of combining various chemical and biological ingredients, including the active medicine, to produce a finalized pharmaceutical product. This process is crucial for modifying and optimizing drugs during the preclinical stage and initial research.

The primary types of dosage forms for drug formulations include oral formulations, parenteral formulations, topical formulations, and inhalation formulations. Oral formulations involve the development and manufacturing of pharmaceuticals intended for oral delivery. They come in various forms such as tablets, capsules, injectables, sprays, suspensions, powders, and others. These formulations are utilized in treating various conditions such as cardiovascular diseases (CVDs), pain, diabetes, cancer, respiratory diseases, among others. End-users of these formulations include big pharmaceutical companies, small and medium enterprises, as well as biotech companies.

The drug formulation market research report is one of a series of new reports from The Business Research Company that provides drug formulation market statistics, including drug formulation industry global market size, regional shares, competitors with a drug formulation market share, detailed drug formulation market segments, market trends and opportunities, and any further data you may need to thrive in the drug formulation industry. This drug formulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug formulation market size has grown strongly in recent years. It will grow from $1908.89 billion in 2024 to $2064.68 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to biopharmaceutical innovation, patient-centric drug development, personalized medicine, regulatory support for orphan drugs, increased R&D investment.

The drug formulation market size is expected to see strong growth in the next few years. It will grow to $2948.64 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to advancements in 3d printing, focus on pediatric formulations, biological drug delivery systems, green chemistry in formulation, integration of artificial intelligence (ai). Major trends in the forecast period include biopharmaceuticals and biologics dominance, advanced drug delivery systems, personalized medicine and individualized formulations, incorporation of nanotechnology, lifecycle management and reformulation strategies.

The increasing prevalence of chronic diseases is anticipated to drive the expansion of the drug formulation market. Chronic diseases persist for a year or longer, demanding continual medical attention and often restricting daily activities. Drug formulation stands as a potential solution to alleviate the prevalence of chronic ailments, employing multiple drug delivery methods to optimize therapeutic effectiveness while minimizing adverse effects. As per a report from the National Institutes of Health (NIH) in September 2022, the United States expects a 99.5% increase in the number of individuals aged 50 and older with at least one chronic illness, rising from 71.52 million in 2020 to an estimated 142.66 million by 2050. Moreover, the count of individuals with multimorbidity is projected to rise by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the growing prevalence of chronic diseases fuels the expansion of the drug formulation market.

The escalating adoption of personalized medicine is poised to drive the growth of the drug formulation market. Personalized medicine represents an innovative healthcare approach tailoring medical treatments and interventions based on individual patient characteristics. This approach necessitates customized drug formulations to optimize efficacy and safety for each patient, considering individual traits such as genetics and biomarkers. The impact includes tailored treatment plans, formulations integrating genomic insights, enhanced drug responses, and personalized therapies for rare diseases. For instance, according to the Personalized Medicine Coalition in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% (12 of them) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Thus, the increasing adoption of personalized medicine is a key driver of growth in the drug formulation market.

Technological advancements emerge as a prominent trend fueling the drug formulation market. Key industry players are directing their focus toward introducing innovative technologies to fortify their market positions. For instance, in June 2022, Merck & Co., Inc., a US-based pharmaceutical company, unveiled the Merck Digital Sciences Studio (MDSS), aiming to develop innovative technologies for drug research and development. Leveraging Azure Cloud's robust computing and Merck's expertise, MDSS collaboratively accelerates the creation of novel digital technologies. The initiative, a collaboration between Merck and the New Jersey Innovation Institute (NJII), has secured investments from the Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures. Microsoft will extend technological support to startup companies involved in the initiative.

Leading companies in the drug formulation market are focusing on the development of new fixed-dose combination drugs for type 2 diabetes to enhance their competitive advantage. A Fixed Dose Combination (FDC) refers to a pharmaceutical formulation that includes two or more active ingredients combined in a specific ratio within a single dosage form. For example, in October 2023, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical firm, launched the first triple-drug fixed-dose combination under the brand name Zita DM. This formulation contains the DPP4 inhibitor Teneligliptin (20 mg), the SGLT2 inhibitor Dapagliflozin (10 mg), and Metformin SR (500 mg/1000 mg) in a fixed dose. It is prescribed to be taken once daily to enhance glycemic control in patients with type 2 diabetes.

In October 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology firm, acquired Biohaven Pharmaceutical Holding Company Ltd. in a deal valued at $11.6 billion. This acquisition adds a portfolio of promising calcitonin gene-related peptide (CGRP) receptor antagonists to Pfizer's offerings. It enhances the potential to provide new treatment options for patients suffering from migraines, a condition that affects over 1 billion people worldwide. Biohaven Pharmaceutical Holding Company Ltd. is a US-based organization dedicated to the discovery, development, and commercialization of transformative treatments and medications in key therapeutic areas.

Major companies operating in the drug formulation market include AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

North America was the largest region in the drug formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug formulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug formulation market includes revenues earned by entities by providing formulation optimization, process optimization, and scale-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Formulation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug formulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug formulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug formulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Dosage Form: Oral formulations; Parenteral Formulations; Topical Formulations; Inhalation Formulations
2) By Formulation: Tablets; Capsules; Injectable; Sprays; Suspensions; Powders; Other Formulations
3) By Therapy Area: Cardiovascular Diseases (CVDs); Pain; Diabetes; Cancer; Respiratory Diseases; Other Diseases
4) By End-User: Big Pharma; Small And Medium Pharma; Biotech Companies
Subsegments:
1) By Oral Formulations: Tablets; Capsules; Powders; Liquids Or Solutions
2) By Parenteral Formulations: Injectables; Implants; Infusions
3) By Topical Formulations: Creams; Ointments; Gels; Transdermal Patches
4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers
Companies Mentioned: AstraZeneca PLC; The Bristol-Myers Squibb Company; Eli Lilly and Company; Gilead Sciences Inc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23321

1. Executive Summary

2. Drug Formulation Market Characteristics

3. Drug Formulation Market Trends And Strategies

4. Drug Formulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Drug Formulation Growth Analysis And Strategic Analysis Framework

5.1. Global Drug Formulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Drug Formulation Market Growth Rate Analysis
5.4. Global Drug Formulation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Drug Formulation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Drug Formulation Total Addressable Market (TAM)

6. Drug Formulation Market Segmentation

6.1. Global Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral formulations
Parenteral Formulations
Topical Formulations
Inhalation Formulations
6.2. Global Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Other Formulations
6.3. Global Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Other Diseases
6.4. Global Drug Formulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Big Pharma
Small And Medium Pharma
Biotech Companies
6.5. Global Drug Formulation Market, Sub-Segmentation Of Oral Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Powders
Liquids Or Solutions
6.6. Global Drug Formulation Market, Sub-Segmentation Of Parenteral Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectables
Implants
Infusions
6.7. Global Drug Formulation Market, Sub-Segmentation Of Topical Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Creams
Ointments
Gels
Transdermal Patches
6.8. Global Drug Formulation Market, Sub-Segmentation Of Inhalation Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metered-Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Nebulizers

7. Drug Formulation Market Regional And Country Analysis

7.1. Global Drug Formulation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Drug Formulation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Formulation Market

8.1. Asia-Pacific Drug Formulation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Formulation Market

9.1. China Drug Formulation Market Overview
9.2. China Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Formulation Market

10.1. India Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Formulation Market

11.1. Japan Drug Formulation Market Overview
11.2. Japan Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Formulation Market

12.1. Australia Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Formulation Market

13.1. Indonesia Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Formulation Market

14.1. South Korea Drug Formulation Market Overview
14.2. South Korea Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Formulation Market

15.1. Western Europe Drug Formulation Market Overview
15.2. Western Europe Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Formulation Market

16.1. UK Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Formulation Market

17.1. Germany Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Formulation Market

18.1. France Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Formulation Market

19.1. Italy Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Formulation Market

20.1. Spain Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Formulation Market

21.1. Eastern Europe Drug Formulation Market Overview
21.2. Eastern Europe Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Formulation Market

22.1. Russia Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Formulation Market

23.1. North America Drug Formulation Market Overview
23.2. North America Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Formulation Market

24.1. USA Drug Formulation Market Overview
24.2. USA Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Formulation Market

25.1. Canada Drug Formulation Market Overview
25.2. Canada Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Formulation Market

26.1. South America Drug Formulation Market Overview
26.2. South America Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Formulation Market

27.1. Brazil Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Formulation Market

28.1. Middle East Drug Formulation Market Overview
28.2. Middle East Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Formulation Market

29.1. Africa Drug Formulation Market Overview
29.2. Africa Drug Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Drug Formulation Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Drug Formulation Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Formulation Market Competitive Landscape And Company Profiles

30.1. Drug Formulation Market Competitive Landscape
30.2. Drug Formulation Market Company Profiles
- 30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. The Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Drug Formulation Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Pfizer Inc.
31.3. AbbVie Inc.
31.4. C.H. Boehringer Sohn AG & Co. KG
31.5. F. Hoffmann-La Roche AG
31.6. Johnson & Johnson
31.7. Bayer AG
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Sanofi S.A.
31.10. GlaxoSmithKline plc
31.11. Novo Nordisk A/S
31.12. Amgen Inc.
31.13. Viatris Inc.
31.14. Sandoz International GmbH
31.15. Takeda Pharmaceutical Company Limited

32. Global Drug Formulation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Formulation Market

34. Recent Developments In The Drug Formulation Market

35. Drug Formulation Market High Potential Countries, Segments and Strategies

35.1 Drug Formulation Market In 2029 - Countries Offering Most New Opportunities
35.2 Drug Formulation Market In 2029 - Segments Offering Most New Opportunities
35.3 Drug Formulation Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer